Your browser doesn't support javascript.
loading
Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3.
Tong, Guoyu; Lu, Song; Kuang, Hongyu; Li, Yan; Deng, Yuying; Lou, Ying; Wang, Weimin; Zhu, Dalong.
Afiliación
  • Tong G; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
  • Lu S; Chongqing General Hospital, Chongqing, China.
  • Kuang H; Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li Y; Department of Endocrinology and Metabolism, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Deng Y; Lilly China Drug Development and Medical Affairs Center, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd., Shanghai, China.
  • Lou Y; Lilly China Drug Development and Medical Affairs Center, Eli Lilly (Suzhou) Pharmaceutical Co., Ltd., Shanghai, China.
  • Wang W; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
  • Zhu D; Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, China.
Diabetes Obes Metab ; 26(4): 1540-1543, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38185739
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: China